Nov 30, 2018 5:01 pm EST QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
Oct 1, 2018 7:00 am EDT NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018
Sep 12, 2018 8:14 am EDT NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier
Jul 24, 2018 7:00 am EDT NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog
